47 In patients with overweight or obesity without diabetes, the Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1) trial showed that tirzepatide 15 mg weekly led to a mean body weight reduction of 20.9% after 72 weeks of treatment, compared with 3.1% with placebo
From supporting immunity and glowing skin to keeping your liver and cells functioning optimally, this antioxidant is worth your attention
Glutathione Creams and Serums Glutathione creams and serums are topical skincare products designed to deliver antioxidant benefits directly to the skins surface
Differentiating between cardiac chest pain and other causes in patients taking tirzepatide requires careful clinical assessment
03See Slow PCOS Progress as a Trend, Not a Failure PCOS-related weight change can feel slower and less linear than people expect, which is one reason a generic weight app often misses the emotional reality of the journey
Evidence Boundaries Consumers should understand the distinction between ingredient-level evidence and product-level evidence when evaluating any compounded GLP-1 offering
